• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Pathophysiological research of AGEs-RAGE system and Fetuin-A on bone metabolism and arteriosclerosis

Research Project

Project/Area Number 20791039
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeSingle-year Grants
Research Field Orthopaedic surgery
Research InstitutionShimane University

Principal Investigator

YAMAMOTO Masahiro  Shimane University, 医学部, 助教 (50346392)

Project Period (FY) 2008 – 2009
Project Status Completed (Fiscal Year 2009)
Budget Amount *help
¥3,120,000 (Direct Cost: ¥2,400,000、Indirect Cost: ¥720,000)
Fiscal Year 2009: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2008: ¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
Keywords2型糖尿病 / 骨粗鬆症 / 椎体骨折 / ペントシジン / 終末糖化物質受容体 / esRAGE骨質 / esRAGE / 骨質 / 糖化終末物質
Research Abstract

Type 2 diabetes is independent risk factor of vertebral fracture. These fractures are not predicted by bone mineral density, indicating that patients with type 2 diabetes have poor bone quality. Vertebral fractures risk is associated with increased serum level of advanced glycation end-products (AGEs) or with relatively insufficient amount of endogenous secretory receptor for AGEs (esRAGE). These results suggest that AGEs-RAGE system affect bone quality. On the other hand, intima media thickness of internal carotid artery, which is one of index of arteriosclerosis, is related with vertebral fractures, suggesting that vertebral fractures and atherosclerosis have common pathologic condition.

Report

(3 results)
  • 2009 Annual Research Report   Final Research Report ( PDF )
  • 2008 Annual Research Report
  • Research Products

    (86 results)

All 2012 2010 2009 2008

All Journal Article (54 results) (of which Peer Reviewed: 33 results) Presentation (30 results) Book (2 results)

  • [Journal Article] Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus.2010

    • Author(s)
      Yamamoto M (3番目, 他6名)
    • Journal Title

      Osteoporos Int (in press)

    • Related Report
      2009 Final Research Report
    • Peer Reviewed
  • [Journal Article] Relationship between treatments with insulin and oral hypoglycemic agents versus the presence of vertebral fractures in type 2 diabetes mellitus.2010

    • Author(s)
      Yamamoto M (3番目, 他3名)
    • Journal Title

      J Bone Miner Metab (in press)

    • NAID

      10027684019

    • Related Report
      2009 Final Research Report
    • Peer Reviewed
  • [Journal Article] Baseline atherosclerosis parameter could assess the risk of bone loss during pioglitazone treatment in type 2 diabetes mellitus.2010

    • Author(s)
      Yamamoto M (3番目, 他6名)
    • Journal Title

      Osteoporos Int (in press)

    • Related Report
      2009 Final Research Report
    • Peer Reviewed
  • [Journal Article] Baseline atherosclerosis parameter could assess the risk of bone loss during pioglitazone treatment in type 2 diabetes mellitus2010

    • Author(s)
      Kanazawa I
    • Journal Title

      Osteoporos Int ((in press))

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus2010

    • Author(s)
      Kanazawa I
    • Journal Title

      Osteoporos Int ((in press))

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Relationship between treatments with insulin and oral hypoglycemic agents versus the presence of vertebral fractures in type 2 diabetes mellitus2010

    • Author(s)
      Kanazawa I
    • Journal Title

      J Bone Miner Metab ((in press))

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Diabetic patients have an increased risk of vertebral fractures independent of bone mineral density or diabetic complications.2009

    • Author(s)
      Yamamoto M (, 他4名)
    • Journal Title

      J Bone Miner Res 24

      Pages: 702-709

    • Related Report
      2009 Final Research Report
    • Peer Reviewed
  • [Journal Article] Low serum level of the endogenous secretory receptor for advanced glycation end-products (esRAGE) is a risk factor for prevalent vertebral fractures independent of bone mineral density in patients with type 2 diabetes.2009

    • Author(s)
      Yamamoto M (, 他3名)
    • Journal Title

      Diabetes Care 32

      Pages: 2263-2268

    • Related Report
      2009 Final Research Report
    • Peer Reviewed
  • [Journal Article] Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus.2009

    • Author(s)
      Yamamoto M, (3番目, 他6名)
    • Journal Title

      J Clin Endocrinol Metab. 94

      Pages: 45-49

    • Related Report
      2009 Final Research Report
    • Peer Reviewed
  • [Journal Article] Adiponectin is associated with changes in bone markers during glycemic control in type 2 diabetes mellitus.2009

    • Author(s)
      Yamamoto M (3番目, 他5名)
    • Journal Title

      J Clin Endocrinol Metab 94

      Pages: 3031-3037

    • NAID

      40016591700

    • Related Report
      2009 Final Research Report
    • Peer Reviewed
  • [Journal Article] Bone fragility in male glucocorticoid-induced osteoporosis is not defined by bone mineral density.2009

    • Author(s)
      Yamamoto M (2番目, 他6名)
    • Journal Title

      Osteoporos Int 20

      Pages: 1889-1894

    • Related Report
      2009 Final Research Report
    • Peer Reviewed
  • [Journal Article] Associations between components of the metabolic syndrome versus bone mineral density and vertebral fractures in patients with type 2 diabetes.2009

    • Author(s)
      Yamamoto M (3番目, 他6名)
    • Journal Title

      Bone 45

      Pages: 174-179

    • Related Report
      2009 Final Research Report
    • Peer Reviewed
  • [Journal Article] Parathyroid hormone up-regulates BMP-2 mRNA expression through mevalonate kinase and Rho kinase inhibition in osteoblastic MC3T3-E1 cells.2009

    • Author(s)
      Yamamoto M (3番目, 他6名)
    • Journal Title

      Horm Metab Res 41

      Pages: 861-865

    • Related Report
      2009 Final Research Report
    • Peer Reviewed
  • [Journal Article] Relationships between serum adiponectin levels versus bone mineral density, bone metabolic markers, and vertebral fractures in type 2 diabetes mellitus.2009

    • Author(s)
      Yamamoto M, (3番目, 他5名)
    • Journal Title

      Eur J Endocrinol. 160

      Pages: 265-273

    • Related Report
      2009 Final Research Report
    • Peer Reviewed
  • [Journal Article] Serum osteocalcin/bone-specific alkaline phosphatase ratio is a predictor for the presence of vertebral fractures in men with type 2 diabetes.2009

    • Author(s)
      Yamamoto M (3番目, 他5名)
    • Journal Title

      Calcif Tissue Int s 85

      Pages: 228-234

    • Related Report
      2009 Final Research Report
    • Peer Reviewed
  • [Journal Article] BMP/Wnt antagonists are upregulated by dexamethasone in osteoblasts and reversed by alendronate and PTH: Potential therapeutic targets for glucocorticoid-induced osteoporosis.2009

    • Author(s)
      Yamamoto M, (6番目, 他6名)
    • Journal Title

      Biochem Biophys Res Commun. 379

      Pages: 261-266

    • Related Report
      2009 Final Research Report
    • Peer Reviewed
  • [Journal Article] 骨質マーカーとしてのペントシジン.2009

    • Author(s)
      山本昌弘
    • Journal Title

      腎と骨代謝 22

      Pages: 245-250

    • Related Report
      2009 Final Research Report
  • [Journal Article] 糖尿病患者の骨粗鬆症・骨折をめぐる話題.2009

    • Author(s)
      山本昌弘(, 他1名)
    • Journal Title

      綜合臨床 58

      Pages: 2424-2427

    • Related Report
      2009 Final Research Report
  • [Journal Article] 糖尿病における骨折危険性とその評価.2009

    • Author(s)
      山本昌弘
    • Journal Title

      腎と骨代謝 23

      Pages: 27-33

    • Related Report
      2009 Final Research Report
  • [Journal Article] 連載EBM講座2型糖尿病患者は骨折しやすいか.2009

    • Author(s)
      山本昌弘、(, 他1名)
    • Journal Title

      骨粗鬆症治療 8

      Pages: 49-53

    • Related Report
      2009 Final Research Report
  • [Journal Article] 生活習慣病のPPAR分子標的薬チアゾリジンとフィブラート2型糖尿病女性に対する骨折のリスクとその対応.2009

    • Author(s)
      山本昌弘
    • Journal Title

      薬局 60

      Pages: 289-292

    • Related Report
      2009 Final Research Report
  • [Journal Article] 2型糖尿病における内因性分泌型終末糖化物質受容体(esRAGE)と骨脆弱性との関連の検討.2009

    • Author(s)
      山本昌弘(, 他3名)
    • Journal Title

      Osteoporosis Japan 17

      Pages: 659-665

    • Related Report
      2009 Final Research Report
  • [Journal Article] 血糖コントロール不良な2型糖尿病患者の短期治療介入における骨代謝マーカー、アディポネクチンの経時的推移とその変化量の相互関連性についての検討.2009

    • Author(s)
      山本昌弘(3番目, 他5名)
    • Journal Title

      Osteoporosis Japan 17

      Pages: 222-225

    • Related Report
      2009 Final Research Report
  • [Journal Article] Diabetic patients have an increased risk of vertebral fractures independent of bone mineral density or diabetic complications2009

    • Author(s)
      Yamamoto M
    • Journal Title

      J Bone Miner Res 24

      Pages: 702-709

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Bone fragility in male glucocorticoid-induced osteoporosis is not defined by bone mineral density2009

    • Author(s)
      Hayashi K
    • Journal Title

      Osteoporos Int 20

      Pages: 1889-1894

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Associations between components of the metabolic syndrome versus bone mineral density and vertebral fractures in patients with type 2 diabetes2009

    • Author(s)
      Yamaguchi T
    • Journal Title

      Bone 45

      Pages: 174-179

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Low. serum level of the endogenous secretory receptor for advanced glycation end-products(esRAGE)is a risk factor for prevalent vertebral fractures independent of bone mineral density in patients with type 2 diabetes2009

    • Author(s)
      Yamamoto M
    • Journal Title

      Diabetes Care 32

      Pages: 2263-2268

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Parathyroid hormone up-regulates BMP-2 mRNA expression through mevalonate kinase and Rho kinase inhibition in osteoblastic MC3T3-E1 cells2009

    • Author(s)
      Takase H
    • Journal Title

      Horm Metab Res 41

      Pages: 861-865

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Serum osteocalcin/bone-specific alkaline phosphatase ratio is a predictor for the presence of vertebral fractures in men with type 2 diabetes2009

    • Author(s)
      Kanazawa I
    • Journal Title

      Calcif Tissue Int 85

      Pages: 228-234

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Adiponectin is associated with changes in bone markers during glycemic control in type 2 diabetes mellitus2009

    • Author(s)
      Kanazawa I
    • Journal Title

      J Clin Endocrinol Metab 94

      Pages: 3031-3037

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] 2型糖尿病における内因性分泌型終末糖化物質受容体(esRAGE)と骨脆弱性との関連の検討2009

    • Author(s)
      山本昌弘
    • Journal Title

      Osteoporosis Japan 17

      Pages: 659-665

    • Related Report
      2009 Annual Research Report
  • [Journal Article] 血糖コントロール不良な2型糖尿病患者の短期治療介入における骨代謝マーカー、アディポネクチンの経時的推移とその変化量の相互関連性についての検討2009

    • Author(s)
      金沢一平
    • Journal Title

      Osteoporosis Japan 17

      Pages: 222-225

    • Related Report
      2009 Annual Research Report
  • [Journal Article] 骨質マーカーとしてのペントシジン2009

    • Author(s)
      山本昌弘
    • Journal Title

      腎と骨代謝 22

      Pages: 245-250

    • Related Report
      2009 Annual Research Report
  • [Journal Article] 糖尿病患者の骨粗鬆症・骨折をめぐる話題2009

    • Author(s)
      山本昌弘
    • Journal Title

      綜合臨床 58

      Pages: 2424-2427

    • Related Report
      2009 Annual Research Report
  • [Journal Article] 糖尿病における骨折危険性とその評価2009

    • Author(s)
      山本昌弘
    • Journal Title

      腎と骨代謝 23

      Pages: 27-33

    • Related Report
      2009 Annual Research Report
  • [Journal Article] BMP/Wnt antagonists are upregdlated by dexamethasone in osteoblasts and reversed by alendronate and PTH : Potential therapeutic targets for glucocorticoid-induced osteoporosis2009

    • Author(s)
      Hayashi K
    • Journal Title

      Biochem Biophys Res Commun 379

      Pages: 261-266

    • Related Report
      2008 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus2009

    • Author(s)
      Kanazawa I
    • Journal Title

      J Clin Endocrinol Metab 94

      Pages: 45-49

    • Related Report
      2008 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Relationships between serum adiponectin levels versus bone mineral density, bone metabolic markers, and vertebral fractures in type 2 diabetes mellitus2009

    • Author(s)
      Kanazawa I
    • Journal Title

      Eur J Endocrinol 160

      Pages: 265-273

    • Related Report
      2008 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Bone fragility in male glucocorticoid-indubed osteoporosis is not defined by bone mineral density2009

    • Author(s)
      Hayashi K
    • Journal Title

      Osteoporos Int (印刷中)

    • Related Report
      2008 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Diabetic patients have an increased risk of vertebral fractures independent of bone mineral density or diabetic complications2009

    • Author(s)
      Yamamoto M
    • Journal Title

      J Bone Miner Res (印刷中)

    • Related Report
      2008 Annual Research Report
    • Peer Reviewed
  • [Journal Article] 生活習慣病のPPAR分子標的薬チアゾリジンとフィブラート2型糖尿病女性に対する骨折のリスクとその対応2009

    • Author(s)
      山本昌弘
    • Journal Title

      薬局 60

      Pages: 289-292

    • Related Report
      2008 Annual Research Report
  • [Journal Article] Serum pentosidine level is positively associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes.2008

    • Author(s)
      Yamamoto M, (他4名)
    • Journal Title

      J Clin Endocrinol Metab 93

      Pages: 1013-1019

    • Related Report
      2009 Final Research Report
    • Peer Reviewed
  • [Journal Article] Combination of Obesity with Hyperglycemia is a Risk Factor for the Presence of Vertebral Fractures in Type 2 Diabetic Men.2008

    • Author(s)
      Yamamoto M, (3番目, 他5名)
    • Journal Title

      Calcif Tissue Int 83

      Pages: 324-331

    • Related Report
      2009 Final Research Report
    • Peer Reviewed
  • [Journal Article] Serum DHEA-S level is associated with the presence of atherosclerosis in postmenopausal women with type 2 diabetes mellitus.2008

    • Author(s)
      Yamamoto M, (3番目, 他6名)
    • Journal Title

      Endocr J 55

      Pages: 667-675

    • NAID

      10022609033

    • Related Report
      2009 Final Research Report
    • Peer Reviewed
  • [Journal Article] 2型糖尿病女性の血中ペントシジン濃度は椎体骨折の予測因子である.2008

    • Author(s)
      山本昌弘, (他4名)
    • Journal Title

      Osteoporosis Japan 16

      Pages: 118-122

    • Related Report
      2009 Final Research Report
  • [Journal Article] 男性ステロイド性骨粗鬆症における腰椎・大腿骨頸部・橈骨骨密度での椎体骨折閾値の検討.2008

    • Author(s)
      山本昌弘、(2番目他5名)
    • Journal Title

      Osteoporosis Japan 16

      Pages: 110-113

    • Related Report
      2009 Final Research Report
  • [Journal Article] 男性2型糖尿病において肥満かつ血糖コントロール不良であることは多発椎体骨折の危険因子である.2008

    • Author(s)
      山本昌弘、(3番目, 他5名)
    • Journal Title

      Osteoporosis Japan 16

      Pages: 73-75

    • Related Report
      2009 Final Research Report
  • [Journal Article] 2型糖尿病における血中アディポネクチンの骨密度、骨質、骨脆弱性への関与の検討.2008

    • Author(s)
      山本昌弘、(3番目, 他5名)
    • Journal Title

      Osteoporosis Japan 16

      Pages: 632-635

    • Related Report
      2009 Final Research Report
  • [Journal Article] Serum DHEA-S level is associated with the presence of athero sclerosis in postmenopausal women with type 2 diabetes mellitus2008

    • Author(s)
      Kanazawa I
    • Journal Title

      Endocr J 55

      Pages: 667-675

    • Related Report
      2008 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Combination of Obesity with Hyperglycemia is a Risk Factor for the Presence of Vertebral Fractures in Type 2 Diabetic Men2008

    • Author(s)
      Kanazawa I
    • Journal Title

      Calcif Tissue Int 83

      Pages: 324-31

    • Related Report
      2008 Annual Research Report
    • Peer Reviewed
  • [Journal Article] 2型糖尿病女性の血中ペントシジン濃度は椎体骨折の予測因子である2008

    • Author(s)
      山本昌弘
    • Journal Title

      Osteoporosis Japan 16

      Pages: 118-122

    • Related Report
      2008 Annual Research Report
  • [Journal Article] 男性ステロイド性骨粗鬆症における腰椎・大腿骨頸部・橈骨骨密度での椎体骨折閾値の検討2008

    • Author(s)
      林公美
    • Journal Title

      Osteopordsis Japan 16

      Pages: 110-113

    • Related Report
      2008 Annual Research Report
  • [Journal Article] 男性2型糖尿病において肥満かつ血糖コントロール不良であることは多発椎体骨折の危険因子である2008

    • Author(s)
      金沢一平
    • Journal Title

      Osteoporosis Japan 16

      Pages: 73-75

    • Related Report
      2008 Annual Research Report
  • [Journal Article] 2型糖尿病における血中アディポネクチンの骨密度、骨質、骨脆弱性への関与の検討2008

    • Author(s)
      金沢一平
    • Journal Title

      Osteoporosis Japan 16

      Pages: 632-635

    • Related Report
      2008 Annual Research Report
  • [Presentation] ストロンチウムの骨芽細胞活性化、骨形成促進作用におけるカルシウム感知受容体の関与2010

    • Author(s)
      高岡伸
    • Organizer
      第83回日本内分泌学会学術総会
    • Place of Presentation
      京都
    • Year and Date
      2010-03-26
    • Related Report
      2009 Annual Research Report 2009 Final Research Report
  • [Presentation] Serum Level of an Endogenous Secretory Receptor for Advanced Glycation End-products (esRAGE) Is Useful for Assessing the Risk of Prevalent Vertebral Fractures Independent of BMD in Patients with Type 2 Diabetes.2010

    • Author(s)
      Yamamoto M
    • Organizer
      14th International Congress of Endocrinology.
    • Place of Presentation
      Kyoto
    • Related Report
      2009 Final Research Report
  • [Presentation] Serum Level of an Endogenous Secretory Receptor for Advanced Glycation End-products(esRAGE)Is Useful for Assessing the Risk of Prevalent Vertebral Fractures Independent of BMD in Patients with Type 2 Diabetes2010

    • Author(s)
      Yamamoto M
    • Organizer
      14^<th> International Congress of Endocrinology
    • Place of Presentation
      Kyoto
    • Related Report
      2009 Annual Research Report
  • [Presentation] 2型糖尿病における可溶性終末糖化物質受容体(esRAGE)は、骨密度とは独立した椎体骨折の危険因子である2009

    • Author(s)
      山本昌弘
    • Organizer
      第11回日本骨粗鬆症学会
    • Place of Presentation
      名古屋
    • Related Report
      2009 Annual Research Report 2009 Final Research Report
  • [Presentation] Serum Level of an Endogenous Secretory Receptor for Advanced Glycation End-products (esRAGE) Is Useful for Assessing the Risk of Prevalent Vertebral Fractures Independent of BMD in Patients with Type 2 Diabetes.2009

    • Author(s)
      Yamamoto M
    • Organizer
      American Society for Bone and Mineral Research 31st Annual Meeting.
    • Place of Presentation
      Denver
    • Related Report
      2009 Final Research Report
  • [Presentation] Associations between components of the metabolic syndrome versus bone mineral density and vertebral fractures in patients with type 2 diabetes.2009

    • Author(s)
      Yamaguchi T
    • Organizer
      American Society for Bone and Mineral Research 31st Annual Meeting.
    • Place of Presentation
      Denver
    • Related Report
      2009 Final Research Report
  • [Presentation] 腎障害のない2型糖尿病の低骨形成にPTH分泌障害が関与する割2009

    • Author(s)
      山本昌弘
    • Organizer
      第27回日本骨代謝学会
    • Place of Presentation
      大阪
    • Related Report
      2009 Final Research Report
  • [Presentation] 骨芽細胞におけるAMP-kinaseおよびメバロン酸経路の役割2009

    • Author(s)
      山口徹
    • Organizer
      第82回日本内分泌学会学術総会
    • Place of Presentation
      前橋
    • Related Report
      2009 Annual Research Report 2009 Final Research Report
  • [Presentation] ステロイド骨粗鬆症に対するビスホスホネート、PTHの薬理作用の解明2009

    • Author(s)
      林公美
    • Organizer
      第82回日本内分泌学会学術総会
    • Place of Presentation
      前橋
    • Related Report
      2009 Annual Research Report 2009 Final Research Report
  • [Presentation] シナカルセトの血清Ca低下作用に骨吸収、骨形成のアンカップリングが関与する2009

    • Author(s)
      矢野彰三
    • Organizer
      第82回日本内分泌学会学術総会
    • Place of Presentation
      前橋
    • Related Report
      2009 Annual Research Report 2009 Final Research Report
  • [Presentation] 2型糖尿病における血中オステオカルシンの糖・脂質代謝、動脈硬化指標への関与の検討2009

    • Author(s)
      金沢一平
    • Organizer
      第82回日本内分泌学会学術総会
    • Place of Presentation
      前橋
    • Related Report
      2009 Annual Research Report 2009 Final Research Report
  • [Presentation] Undercarboxylated osteocalcin / osteocalcin ratio is negatively associated with hyperglycemic conditions, but not with the presence of vertebral fractures, in patients with type 2 diabetes.2009

    • Author(s)
      Yamamoto M
    • Organizer
      2nd Joint Meeting of the International Bone & Mineral Society and the Australian and New Zealand Bone and Mineral Society.
    • Place of Presentation
      Sydney
    • Related Report
      2009 Final Research Report
  • [Presentation] BMP/Wnt antagonists are upregulated by dexamethasone in osteoblasts and reversed by alendronate and PTH: Potential therapeutic targets for glucocorticoid-induced osteoporosis.2009

    • Author(s)
      Yamaguchi T
    • Organizer
      2nd Joint Meeting of the International Bone & Mineral Society and the Australian and New Zealand Bone and Mineral Society
    • Place of Presentation
      Sydney
    • Related Report
      2009 Final Research Report
  • [Presentation] Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus.2009

    • Author(s)
      Yamaguchi T
    • Organizer
      2nd Joint Meeting of the International Bone & Mineral Society and the Australian and New Zealand Bone and Mineral Society
    • Place of Presentation
      Sydney
    • Related Report
      2009 Final Research Report
  • [Presentation] Serum Level of an Endogenous Secretory Receptor for Advanced Glycation End-products(esRAGE)Is Useful for Assessing the Risk of Prevalent Vertebral Fractures Independent of BMD in Patients with Type 2 Diabetes.2009

    • Author(s)
      Yamamoto M
    • Organizer
      American Society for Bone and Mineral Research 31^<st> Annual Meeting
    • Place of Presentation
      Denver
    • Related Report
      2009 Annual Research Report
  • [Presentation] Associations between components of the metabolic syndrome versus bone mineral density and vertebral fractures in patients with type 2 diabetes2009

    • Author(s)
      Yamaguchi T
    • Organizer
      American Society for Bone and Mineral Research 31^<st> Annual Meeting
    • Place of Presentation
      Denver
    • Related Report
      2009 Annual Research Report
  • [Presentation] 腎障害のない2型糖尿病の低骨形成にPTH分泌障害が関与する2009

    • Author(s)
      山本昌弘
    • Organizer
      第27回日本骨代謝学会
    • Place of Presentation
      大阪
    • Related Report
      2009 Annual Research Report
  • [Presentation] Undercarboxylated osteocalcin/osteocalcin ratio is negatively associated with hyperglycemic conditions, but not with the presence of vertebial fractures, in patients with type 2 diabetes2009

    • Author(s)
      Yamamoto M
    • Organizer
      2nd Joint Meeting of the International Bone & Mineral Society and the Australian and New Zealand Bone and Mineral Society
    • Place of Presentation
      Sydney
    • Related Report
      2008 Annual Research Report
  • [Presentation] BMP/Wnt antagonists are upregulated by dexamethasone in osteoblasts and reversed by alendronate and PTH : Potential therapeutic targets for glucocorticoid-induced osteoporosis2009

    • Author(s)
      Yamaguchi T
    • Organizer
      2nd Joint Meeting of the International Bone & Mineral Society and the Australian and New Zealand Bone and Mineral Society
    • Place of Presentation
      Sydney
    • Related Report
      2008 Annual Research Report
  • [Presentation] Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus2009

    • Author(s)
      Yamaguchi T
    • Organizer
      2nd joint Meeting of the Inteational Bone & Mineral Society and the Australian and New Zealand Bone and Mineral Society
    • Place of Presentation
      Sydney
    • Related Report
      2008 Annual Research Report
  • [Presentation] 2型糖尿病における血中アディポネクチシの骨代謝への関与の検討〜男性2型糖尿病においては総アディポネクチン値が骨脆弱性の指標となりうる〜2008

    • Author(s)
      金沢一平
    • Organizer
      第10回日本骨粗鬆学会
    • Place of Presentation
      大阪
    • Year and Date
      2008-11-01
    • Related Report
      2008 Annual Research Report
  • [Presentation] 血糖コントロール不良な2型糖尿病患者の短期治療介入における骨代謝マーカー、アディポネクチンの経時的推移とその変化量の相互関連性についての検討2008

    • Author(s)
      金沢一平
    • Organizer
      第10回日本骨粗鬆症学会
    • Place of Presentation
      大阪
    • Year and Date
      2008-11-01
    • Related Report
      2008 Annual Research Report
  • [Presentation] 閉経後2型糖尿病患都こおけるHip structure analysisによる大腿骨皮質骨構造の解析(第一報)2008

    • Author(s)
      山本昌弘
    • Organizer
      第10回日本骨粗鬆症学会
    • Place of Presentation
      大阪
    • Year and Date
      2008-10-31
    • Related Report
      2008 Annual Research Report
  • [Presentation] 閉経後2型糖尿病女性における動脈硬化指標と椎体骨折危険度との関連性-骨血管連関の存在2008

    • Author(s)
      山本昌弘
    • Organizer
      第81回日本内分泌学会学術総会
    • Place of Presentation
      青森
    • Year and Date
      2008-05-16
    • Related Report
      2008 Annual Research Report
  • [Presentation] 男性2型糖尿病患者において骨芽細胞成熟の指標(オステオカルシン/骨型ALP比)は骨密度非依存性に椎体骨折の存在を予測しえる2008

    • Author(s)
      金沢一平
    • Organizer
      第26回日本骨代謝学会
    • Place of Presentation
      大阪
    • Related Report
      2009 Final Research Report 2008 Annual Research Report
  • [Presentation] 閉経後2型糖尿病患者におけるHip structure analysisによる大腿骨皮質骨構造の解析2008

    • Author(s)
      山本昌弘
    • Organizer
      第10回日本骨粗鬆症学会
    • Place of Presentation
      大阪
    • Related Report
      2009 Final Research Report
  • [Presentation] 2型糖尿病における血中アディポネクチンの骨代謝への関与の検討~男性2型糖尿病においては総アディポネクチン値が骨脆弱性の指標となりうる~2008

    • Author(s)
      金沢一平
    • Organizer
      第10回日本骨粗鬆症学会
    • Place of Presentation
      大阪
    • Related Report
      2009 Final Research Report
  • [Presentation] 男性2型糖尿病において肥満かつ血糖コントロール不良であることは多発椎体骨折の危険因子である2008

    • Author(s)
      金沢一平
    • Organizer
      第10回日本骨粗鬆症学会
    • Place of Presentation
      大阪
    • Related Report
      2009 Final Research Report 2008 Annual Research Report
  • [Presentation] 閉経後2型糖尿病女性における動脈硬化指標と椎体骨折危険度との関連性-骨血管連関の存在2008

    • Author(s)
      山本昌弘
    • Organizer
      第81回日本内分泌学会学術総会
    • Place of Presentation
      弘前
    • Related Report
      2009 Final Research Report
  • [Presentation] 2型糖尿病には骨密度に反映されない骨脆弱性が存在する2008

    • Author(s)
      山本昌弘
    • Organizer
      第105回日本内科学会総会・講演会
    • Place of Presentation
      東京
    • Related Report
      2009 Final Research Report 2008 Annual Research Report
  • [Book] 糖尿病最新の治療2012

    • Author(s)
      山本昌弘
    • Publisher
      南江堂
    • Related Report
      2009 Final Research Report
  • [Book] 糖尿病 最新の治療,2010-20122010

    • Author(s)
      山本昌弘
    • Publisher
      南江堂
    • Related Report
      2009 Annual Research Report

URL: 

Published: 2008-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi